Sun Pharma ltd - walk in drives for production and QC on 19th May 2019
About Sun Pharma Ltd:-
Mr. Dilip Sanghvi founded Sun Pharmaceuticals in 1983 at Vapi in Gujarat. In 1987, cardiology products were started in 1989 with gastroenterology products. Today, India's largest christianity is a market leader in psychiatry, neurology, cardiology, orthopedics, nethylmology, gastroenterology and nephrology.
The acquisition of Ranbaxy 2014 has made the company the largest pharma company in India, the largest Indian pharma company in the US and the 5th largest private generic company in the world.
More than 72% of Sun Pharma's sales are mostly in the US, outside of India. America is the single largest market that has around 50% turnover; All, formulas or full dosage forms, 98% turnover accounts. The US, Canada, Brazil, Mexico and Israel have a production of 26 places with plants. U.S. In, the US Companies with a strong pipeline awaiting approval from the Food and Drug Administration (FDA), the company markets a large basket of generics.
Sun Pharma listed on 55 issues overburdened by the stock exchange in 1994. The founder is holding most of the family company Sun Pharma is the second largest and most profitable pharmaceutical company in India today, as well as the largest pharmaceutical company in the Indian market with market capitalization.
Indian pharma industry has become the world's third largest producer of volume and is expected to grow to $ 20 billion in 2015. A current 12 billion dollar turnover requires a quotation of . Number 14 in the world
In 2009, San Francisco's Caraco Pharmaceutical plant in Detroit was shut down due to unethical conditions, so that FDA seized $ 20 million for the issue of contamination.
In December 2016, the FDA sent a warning letter to nine violations on its production plant in Hall.
Sun Farm requested USFDA to accept 28 short new drug applications (ANDAS) related to its fully owned subsidiary Ranbaxy Laboratories.
